OnCore Login

Return to Trial Database

HCRN-GI00-2

A Phase II Trial of Irinotecan (CPT-11), 5-Fluorouracil (5-FU), Glutamine, Leucovorin and Celecoxib as First Line Therapy for Metastatic Colorectal Cancer –GI00-2

Status

Study Completed

Cancer Type(s)

Colorectal

Study Contact

Publications

A Phase II Trial of Irinotecan (I), 5-Fluorouracil (F), Leucovorin (L) (IFL), Celecoxib and Glutamine as First Line Therapy for Advanced Colorectal Cancer (CRC)
  • CX Pan, P Loehrer, B Juliar, R Ansari, W Pletcher, C Sweeney
A Phase II Trial of Irinotecan (I), 5-Fluorouracil (F), Leucovorin (L) (IFL), Celecoxib and Glutamine as First Line Therapy for Advanced Colorectal Cancer
  • C Sweeney, D Seitz, R Ansari, W Pletcher, N Chowhan, J Vinson, C Stoner, P Loehrer
A Phase II Trial of Irinotecan, 5-Fluorouracil, Leucovorin, combined with Celecoxib and Glutamine as first line therapy for advanced colorectal cancer
  • CX Pan, PhD, P Loehrer, D Seitz, P Helft, B Juliar, R Ansari, W Pletcher, C Sweeney

Trial Locations

All sites in which the trial HCRN-GI00-2 being conducted in.
No data was found
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278